Cherry is a biomedical company (Organ on Chip) with the mission to replace animal testing by reconstructing human tissues (Organoids) in vitro for drug testing
🚀 Meet our team 🍒 at the NLSDays 2023 in Copenhagen, 29-30 Nov! Explore collaborations potential and discuss CubiX, Organ-on-Chip, Microfluidics Perfusion Lid with our experts.
Book a meeting: https://t.co/Ju1ArzvFke
#organoids#organonchip#vascularized#3dcellculture
🔎 🍒 Discover CubiX - A Complex Representation of Human's Biology - Allows scientists to validate at an early stage (before clinical trials) the safety and efficacy of the drug under development. Learn more: https://t.co/TEkuKNUPgB
#vascularized#organoids#3dcellculture
🌐 Exciting news! Our new website is live at https://t.co/i7xuPKAOzg.
🙏 Your support has been invaluable. At Cherry Biotech, we're committed to providing quality. Please help us by sharing this post and browsing our site. Your feedback is welcome. Thank you! 🙌
Discover how our 3D vascularized & #immunocompetent organoids work in a standard multiwell for drug discovery applications with Cherry Biotech at #FOB2023 in Basel (CH) from Oct 10-12. Visit us at Booth 1010 and meet PharmD/PhD Pierre Gaudriault.
#Organoids#Drugdiscovery
Microphysiological platforms have the potential of creating more effective alternatives to conventional methods in drug development.
https://t.co/p58zDMIaGu
Besides the scientific learning, the fellows gained several other soft skills. One of the main highlights was that they entirely organised a successful international conference to science – From Pole to Pole conference @DivIDE_fptp
The collaboration between the eleven fellows and the training offered within DivIDE was a key factor to successfully undertake each of the planned research goals.